ScholarIQanswers from OpenAlex
Editas Medicine (United States)
InstitutionResearch output, impact & collaborations
Editas Medicine (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Editas Medicine (United States)?
ScholarIQrecord summary
Editas Medicine (United States) is a research organisation in Cambridge, US. OpenAlex records 194 works and 50,625 citations for it. 130 researchers list it as their most recent affiliation.
How many works does Editas Medicine (United States) have?
ScholarIQindexed works
Editas Medicine (United States) has 194 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Editas Medicine (United States) have?
ScholarIQcitation count
Editas Medicine (United States) has 50,625 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Editas Medicine (United States)?
ScholarIQresearcher count
Editas Medicine (United States) has 130 researchers in the ScholarIQ index.
What is the average h-index at Editas Medicine (United States)?
ScholarIQavg h-index
Editas Medicine (United States) has an average h-index of 29.5 in OpenAlex.
What is the ROR of Editas Medicine (United States)?
ScholarIQror
The ROR for Editas Medicine (United States) is on the source record.
What is the OpenAlex record for Editas Medicine (United States)?
ScholarIQopenalex
The OpenAlex for Editas Medicine (United States) is on the source record.
Who are the most-cited researchers behind Editas Medicine (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Editas Medicine (United States)?
ScholarIQmost cited works
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers, Caitlin Connelly, David Fabrizio, Laurie M. Gay, Siraj M. Ali, Riley Ennis, Alexa B. Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin W. Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi A. Garraway, Vincent A. Miller, P. J. Stephens, Garrett M. Frampton
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad, Justin F. Gainor, Alexa B. Schrock, Ryan J. Hartmaier, Sally E. Trabucco, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin, Gaurav Singal, Jeffrey S. Ross, David Fabrizio, Péter M. Szabó, Chang Han, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph D. Szustakowski, Patrik Vitazka, Robin Edwards, José A. Bufill, Neelesh Sharma, Sai‐Hong Ignatius Ou, Nir Peled, David R. Spigel, Hira Rizvi, Elizabeth Jiménez Aguilar, Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach
Comparative Genomics Identifies a Flagellar and Basal Body Proteome that Includes the BBS5 Human Disease Gene
Jin Billy Li, Jantje M. Gerdes, Courtney J. Haycraft, Yanli Fan, Tanya M. Teslovich, Helen May‐Simera, Haitao Li, Oliver E. Blacque, Linya Li, Carmen C. Leitch, Richard A. Lewis, Jane S. Green, Patrick S. Parfrey, Michel R. Leroux, William S. Davidson, Philip L. Beales, Lisa M. Guay‐Woodford, Bradley K. Yoder, Gary D. Stormo, Nicholas Katsanis, Susan K. Dutcher
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
Diana M. Merino, Lisa M. McShane, David Fabrizio, Vincent Funari, Shu‐Jen Chen, James R. White, Paul Wenz, Jonathan Baden, J. Carl Barrett, Ruchi Chaudhary, Li Chen, Wangjuh Chen, Jen‐Hao Cheng, Dinesh Cyanam, Jennifer S. Dickey, Vikas Gupta, Matthew D. Hellmann, Elena Helman, Yali Li, Joerg Maas, Arnaud Papin, Rajesh Patidar, Katie Quinn, Naiyer A. Rizvi, Hongseok Tae, Christine K. Ward, Mingchao Xie, Ahmet Zehir, Chen Zhao, Manfred Dietel, Albrecht Stenzinger, Mark Stewart, Jeff Allen
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Douglas B. Johnson, Garrett M. Frampton, Matthew J. Rioth, Erik Yusko, Yaomin Xu, Xingyi Guo, Riley Ennis, David Fabrizio, Zachary R. Chalmers, Joel Greenbowe, Siraj M. Ali, Sohail Balasubramanian, James Sun, Yuting He, Dennie T. Frederick, Igor Puzanov, Justin M. Balko, Justin Cates, Jeffrey S. Ross, Catherine Sanders, Harlan Robins, Yu Shyr, Vincent A. Miller, Philip J. Stephens, Ryan J. Sullivan, Jeffrey A. Sosman, Christine M. Lovly
How much of the research on Editas Medicine (United States) is open access?
ScholarIQopen access share
100%OPEN ACCESS